Enter Note Done
Go to previous page in this tab
Session
  • Presentation | General Poster Session - Sunday General Poster Session
  • General Poster Session
  • Share Icon
    Map Icon
    Bookmark Icon
  • 1681-P - Benefits of HR17031 vs. Insulin Glargine (iGlar) in Patients (pts) with Type 2 Diabetes (T2D) Uncontrolled on Metformin (Met) with/without One Other Oral Antidiabetic Drug (OAD) [Board No. 1681]
    • Schedule
    Notes
  • 1681-P
    Set Timezone
    •  
    Route Me

L. Ji: None. L. Zhang: None. D. Liu: None. J. Liu: None. L. Li: None. Z. Zeng: None. X. Dong: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. R. Li: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. X. Wu: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd. Z. Ye: Employee; Current; Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Type
Main Session